Isoprenalina Cloridrato S.A.L.F. (Isoprenaline Hydrochloride)

Isoprenaline hydrochloride is a non‑selective beta‑adrenergic agonist. It binds to β1 receptors in the heart, raising cyclic AMP levels, which enhances calcium influx and speeds up pacemaker activity, leading to faster heartbeats and stronger contractions. Simultaneously, it stimulates β2 receptors in airway smooth muscle, causing relaxation and opening of the airways.

The dosage of Isoprenalina Cloridrato is determined by the prescribing clinician based on the patient’s condition, weight, age, and response to therapy. The prescriber will select the appropriate concentration, route (intravenous, intramuscular, or subcutaneous), and infusion rate to achieve the desired clinical effect while monitoring safety.

Safety data for isoprenaline hydrochloride in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Isoprenalina Cloridrato, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed), and required import documentation.

Isoprenaline differs from other cardiac stimulants such as dopamine or dobutamine by being a non‑selective beta‑agonist, providing both β1‑mediated cardiac stimulation and β2‑mediated bronchodilation. This dual action can be advantageous in patients with concurrent cardiac and respiratory needs, whereas other agents may have more selective cardiac effects without bronchodilation.

Isoprenalina Cloridrato should be stored at controlled room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Vials must be kept upright, and any solution that appears discolored or contains particles should be discarded. Follow local regulations for handling injectable pharmaceuticals.

The medication is supplied as a sterile solution for injection and can be given intravenously, intramuscularly, or subcutaneously. Administration is performed by qualified healthcare personnel, often using an infusion pump for intravenous delivery to control the rate and allow rapid titration based on the patient’s response.

Serious risks include life‑threatening arrhythmias, myocardial ischemia, severe hypertension, and pulmonary edema. Patients should be continuously monitored for cardiac rhythm changes, blood pressure fluctuations, and signs of respiratory compromise. Immediate medical intervention is required if any of these severe adverse events occur.

Isoprenalina Cloridrato is contraindicated in patients with known ventricular arrhythmias, uncontrolled hypertension, severe coronary artery disease, or hypersensitivity to isoprenaline or any formulation components. It should also be used with extreme caution in individuals with hyperthyroidism, diabetes, or significant electrolyte imbalances.